| 1 day | +0.17% |
| Manager | Title | Age | Since |
|---|---|---|---|
Jared Rhines
PRN | Corporate Officer/Principal | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/12/20 | Issuer sale | Director | 26,400 | 0.0260% | ||
| 10/12/20 | Tender | General Counsel | 47,782 | 0.0470% | ||
| 10/12/20 | Issuer sale | Director | 26,400 | 0.0260% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.17% | +0.17% | - | - | 1.85B | ||
| -0.30% | -6.68% | +29.12% | +125.42% | 1,200B | ||
| +1.25% | -5.35% | +33.19% | +80.42% | 651B | ||
| +0.94% | -2.99% | +24.73% | +106.93% | 506B | ||
| -0.60% | -1.95% | +27.26% | +67.32% | 377B | ||
| +0.69% | -9.50% | +40.80% | +30.23% | 330B | ||
| +0.41% | -4.70% | +27.23% | +51.59% | 288B | ||
| +0.81% | -4.08% | -1.74% | +32.71% | 272B | ||
| -0.15% | -6.45% | +29.63% | +64.18% | 236B | ||
| -0.06% | -0.98% | +33.15% | +118.99% | 206B | ||
| Average | +0.35% | -4.76% | +27.04% | +75.31% | 452B | |
| Weighted average by Cap. | +0.40% | -5.19% | +28.03% | +87.49% |
Employees
-
Sector
Pharmaceuticals
















